Palonosetron plus dexamethasone versus granisetron plus dexamethasone for prevention of nausea and vomiting during chemotherapy: a double-blind, double-dummy, randomised, comparative phase III trial-Reference-Cited by-同舟云学术

Palonosetron plus dexamethasone versus granisetron plus dexamethasone for prevention of nausea and vomiting during chemotherapy: a double-blind, double-dummy, randomised, comparative phase III trial

Published:2009-02 Issue:2 Volume:10 Page:115-124
ISSN:1470-2045
Container-title:The Lancet Oncology
language:en
Short-container-title:The Lancet Oncology

Author:

Saito Mitsue,Aogi Kenjiro,Sekine Ikuo,Yoshizawa Hirohisa,Yanagita Yasuhiro,Sakai Hiroshi,Inoue Kenichi,Kitagawa Chiyoe,Ogura Takashi,Mitsuhashi Shoichi

Publisher

Elsevier BV

Subject

Oncology

Reference40 articles.

1. Dolasetron. A review of its pharmacology and therapeutic potential in the management of nausea and vomiting induced by chemotherapy, radiotherapy or surgery;Balfour;Drugs,1997

2. Serotonin receptor physiology: relation to emesis;Hasler;Dig Dis Sci,1999

3. Comparative review of 5-HT3 receptor antagonists in the treatment of acute chemotherapy-induced nausea and vomiting;Hesketh;Cancer Invest,2000

4. Incidence of chemotherapy-induced nausea and emesis after modern antiemetics;Grunberg;Cancer,2004

5. Nausea and emesis remain significant problems of chemotherapy despite prophylaxis with 5-hydroxytryptamine-3 antiemetics

Cited by 359 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Research trends on chemotherapy induced nausea and vomiting: a bibliometric analysis;Frontiers in Pharmacology;2024-09-13

2. Integrating nutrition, physical exercise, psychosocial support and antiemetic drugs into CINV management: The road to success;Critical Reviews in Oncology/Hematology;2024-09

3. Olanzapine Plus Triple Antiemetic Therapy for the Prevention of Carboplatin-Induced Nausea and Vomiting: A Randomized, Double-Blind, Placebo-Controlled Phase III Trial;Journal of Clinical Oncology;2024-08-10

4. Dexamethasone-sparing strategies in anthracycline and cyclophosphamide-based chemotherapy with a focus on 5-HT3 receptor antagonists: a network meta-analysis;Frontiers in Oncology;2024-07-26

5. Real hopes in antiemetic therapy;Meditsinskiy sovet = Medical Council;2024-07-25